Aristobet 0.1% Ointment 20g Tube

Aristobet cream or ointment is indicated for the treatment of-

• Eczema in children and adults, including atopic
• Infantile and discoid eczema
• Prurigo nodularis
• Psoriasis (excluding widespread plaque psoriasis)
• Neurodermatoses including lichen simplex and lichen planus
• Seborrhoeic dermatitis
• Contact sensitivity reaction
• Discoid lupus erythematosus and may be used as an adjunct to systemic steroid therapy in generalized erythroderma.

Apply sparingly to the affected area two or three times daily until improvement occurs, then twice daily or less. The usual maximum duration of therapy is three weeks.

There are no significant drug interactions reported with Aristobet Cream/Ointment.

Betamethasone Valerate cream or ointment is contraindicated in the following conditions :

• Hypersensitivity to any of the ingredients in the preparation.
• Rosaceae & acne vulgaris.
• Perioral dermatitis, perianal & genital pruritus.
• Viral infections of the skin, e.g. herpes simplex & chickenpox.
• Primary infected skin lesions caused by fungi or bacteria.
• Dermatoses in children under one year of age.

The following local adverse reactions are more common with the use of high doses, long-term use, and with the use of occlusive dressings of Cream/Ointment: dryness, itching, burning, skin thinning, local irritation, features of hypercorticolism, telangiectasia, striae, skin atrophy. Hypertrichosis, change in pigmentation, secondary infection, perioral dermatitis, allergic contact dermatitis, maceration of the skin, acneform eruption, exacerbation of symptoms.

It should not be used extensively in pregnancy.

Aristobet Cream/Ointment is usually well tolerated, but if signs of hypersensitivity appear, application should be stopped. Long-term continuous topical therapy should be avoided where possible, particularly in children, as adrenal suppression may occur even without occlusion. When extensive areas are treated, sufficient systemic absorption may occur to produce symptoms of hypercorticolism. This effect is more likely if occlusive dressings are used, or if the treatment is prolonged. The face or other areas of the body may exhibit atrophic changes after prolonged treatment. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye, as glaucoma might result. Any spread of the infection requires withdrawal of topical corticosteroid therapy.

Keep below 30°C, away from light & moisture. Keep out of the reach of children.